Stock analysts at Truist Financial started coverage on shares of PACS Group (NYSE:PACS – Get Free Report) in a report issued on Monday, MarketBeat.com reports. The firm set a “buy” rating and a $32.00 price target on the stock. Truist Financial’s price target suggests a potential upside of 28.05% from the stock’s previous close.
Separately, Royal Bank of Canada initiated coverage on PACS Group in a report on Monday. They issued an “outperform” rating and a $30.00 target price on the stock. Six analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $30.50.
View Our Latest Report on PACS Group
PACS Group Price Performance
Insider Activity at PACS Group
In related news, CEO Jason Hulse Murray sold 1,607,142 shares of the stock in a transaction on Monday, April 15th. The stock was sold at an average price of $21.00, for a total value of $33,749,982.00. Following the completion of the sale, the chief executive officer now directly owns 62,754,551 shares of the company’s stock, valued at approximately $1,317,845,571. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
About PACS Group
PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
See Also
- Five stocks we like better than PACS Group
- Stock Splits, Do They Really Impact Investors?
- Garmin Navigates to New Highs Driven By Wearables Trend
- Investing in the High PE Growth Stocks
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- 3 Best Fintech Stocks for a Portfolio Boost
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.